Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer

Breast cancer is the most common cancer among women and a leading cause of death worldwide. Triple negative breast cancer (TNBC) is a highly aggressive subtype which is the most challenging to treat. Due to heterogeneity and a lack of specific molecular targets, small molecule-based chemotherapy is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2022-02, Vol.342, p.31-43
Hauptverfasser: George, Thomashire A., Chen, Max M., Czosseck, Andreas, Chen, Hsiang-Pei, Huang, Hsu-Shan, Lundy, David J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!